See more : International Data Management Limited (IDM.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Procter & Gamble Hygiene and Health Care Limited (PGHH.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Procter & Gamble Hygiene and Health Care Limited, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Steep Hill Inc. (STPH.CN) Income Statement Analysis – Financial Results
- B.P. Marsh & Partners PLC (BPM.L) Income Statement Analysis – Financial Results
- Gerresheimer AG (GXI.SW) Income Statement Analysis – Financial Results
- VERBIO Vereinigte BioEnergie AG (VBVBF) Income Statement Analysis – Financial Results
- Gland Pharma Limited (GLAND.BO) Income Statement Analysis – Financial Results
Procter & Gamble Hygiene and Health Care Limited (PGHH.NS)
About Procter & Gamble Hygiene and Health Care Limited
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies, pants, and baby wipes; laundry products; hair care products; home care products; and oral care products. The company offers its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brand names. It sells its products through retail operations, including mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited is a subsidiary of Procter & Gamble Overseas India BV.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.06B | 39.05B | 37.92B | 35.70B | 29.99B | 29.42B | 24.55B | 23.20B | 24.82B | 23.32B | 20.47B | 16.85B | 12.97B | 10.02B | 9.04B | 7.74B | 6.62B | 5.40B | 5.67B | 6.85B |
| Cost of Revenue | 19.16B | 16.63B | 17.62B | 13.29B | 12.78B | 14.00B | 10.75B | 10.29B | 10.46B | 10.40B | 9.18B | 7.92B | 5.24B | 4.24B | 3.00B | 2.58B | -1.74B | 1.80B | 2.01B | 3.27B |
| Gross Profit | 22.89B | 22.42B | 20.30B | 22.42B | 17.20B | 15.43B | 13.80B | 12.91B | 14.36B | 12.92B | 11.30B | 8.93B | 7.73B | 5.78B | 6.05B | 5.17B | 8.36B | 3.61B | 3.65B | 3.58B |
| Gross Profit Ratio | 54.43% | 57.42% | 53.54% | 62.79% | 57.37% | 52.43% | 56.21% | 55.65% | 57.86% | 55.40% | 55.18% | 53.00% | 59.59% | 57.69% | 66.88% | 66.72% | 126.24% | 66.74% | 64.45% | 52.21% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 543.00K | 16.03M | 22.29M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 439.50M | 555.80M | 490.30M | 324.00M | 398.30M | 362.60M | 448.60M | 417.60M | 340.10M | 307.40M | 281.00M | 0.00 | 1.44B | 1.19B | 922.70M | 0.00 | 740.88M | 1.20B | 961.84M |
| Selling & Marketing | 5.68B | 4.27B | 5.58B | 5.89B | 3.88B | 3.64B | 3.06B | 2.57B | 3.49B | 3.69B | 3.05B | 2.58B | 0.00 | 1.59B | 1.55B | 1.32B | 0.00 | 951.92M | 815.56M | 831.45M |
| SG&A | 5.68B | 4.27B | 6.14B | 6.38B | 4.20B | 4.04B | 3.42B | 3.02B | 3.90B | 4.03B | 3.35B | 2.86B | 0.00 | 3.03B | 2.74B | 2.25B | 0.00 | 1.69B | 2.02B | 1.79B |
| Other Expenses | 0.00 | 405.80M | 300.00K | 70.90M | 102.60M | 145.60M | 5.04B | 5.00M | 5.59B | 5.41B | 4.71B | 4.42B | 5.50B | 965.91M | 951.43M | 563.07M | 151.06M | 454.05M | 73.32M | 102.10M |
| Operating Expenses | 8.14B | 14.32B | 12.36B | 13.84B | 11.25B | 9.69B | 7.84B | 6.73B | 8.69B | 8.41B | 7.27B | 6.57B | 5.50B | 3.99B | 3.69B | 2.81B | -3.06B | 2.15B | 1.78B | 1.90B |
| Cost & Expenses | 24.28B | 30.95B | 29.98B | 27.12B | 24.04B | 23.69B | 18.59B | 17.01B | 19.15B | 18.81B | 16.45B | 14.49B | 10.74B | 8.23B | 6.69B | 5.38B | -4.80B | 3.94B | 3.80B | 5.17B |
| Interest Income | 0.00 | 362.10M | 242.90M | 322.90M | 338.50M | 387.80M | 217.30M | 768.00M | 866.50M | 735.90M | 689.80M | 631.20M | 482.10M | 0.00 | 0.00 | 0.00 | 242.66K | 89.14K | 0.00 | 0.00 |
| Interest Expense | 267.80M | 113.80M | 111.90M | 61.10M | 60.70M | 54.80M | 53.20M | 104.20M | 40.20M | 57.20M | 53.90M | 100.00K | 300.00K | 259.96K | 250.78K | 0.00 | 242.66K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 565.00M | 583.60M | 528.80M | 476.60M | 478.80M | 497.80M | 523.70M | 597.40M | 516.90M | 525.30M | 351.80M | 313.10M | 280.75M | 221.55M | 250.26M | 143.70M | 121.20M | 89.84M | 79.15M | 123.97M |
| EBITDA | 10.22B | 8.98B | 8.43B | 9.18B | 6.42B | 6.21B | 6.44B | 6.79B | 6.21B | 5.06B | 4.96B | 3.18B | 2.51B | 2.01B | 2.62B | 2.50B | 11.54B | 9.86B | 1.95B | 1.80B |
| EBITDA Ratio | 24.31% | 23.28% | 22.80% | 26.44% | 22.55% | 23.06% | 27.01% | 32.64% | 28.29% | 24.67% | 24.68% | 19.45% | 19.36% | 20.05% | 29.02% | 32.83% | 174.23% | 28.75% | 34.61% | 26.28% |
| Operating Income | 17.78B | 8.10B | 7.89B | 8.54B | 5.90B | 5.74B | 5.97B | 6.18B | 5.67B | 4.51B | 4.03B | 2.36B | 2.23B | 1.79B | 2.36B | 2.36B | 11.42B | 1.46B | 1.87B | 1.68B |
| Operating Income Ratio | 42.27% | 20.75% | 20.81% | 23.92% | 19.69% | 19.49% | 24.30% | 26.66% | 22.83% | 19.34% | 19.67% | 13.98% | 17.19% | 17.84% | 26.04% | 30.45% | 172.40% | 27.01% | 33.03% | 24.48% |
| Total Other Income/Expenses | -8.39B | -7.84B | -8.65B | -8.26B | 107.50M | 337.70M | -124.90M | 533.30M | 689.60M | -5.95B | 577.30M | 506.50M | -329.16K | -259.96K | -19.08M | -40.62M | -31.87M | -4.50M | 25.49M | 534.44M |
| Income Before Tax | 9.39B | 8.39B | 7.90B | 8.70B | 5.94B | 6.07B | 5.82B | 6.72B | 6.37B | 5.01B | 4.60B | 2.86B | 2.23B | 1.77B | 2.34B | 2.32B | 1.81B | 1.45B | 1.93B | 1.78B |
| Income Before Tax Ratio | 22.33% | 21.50% | 20.83% | 24.37% | 19.81% | 20.64% | 23.70% | 28.96% | 25.65% | 21.47% | 22.49% | 16.99% | 17.19% | 17.64% | 25.83% | 29.92% | 27.26% | 26.92% | 34.12% | 25.96% |
| Income Tax Expense | 2.64B | 1.61B | 2.14B | 2.18B | 1.61B | 1.88B | 2.07B | 2.39B | 2.13B | 1.55B | 1.58B | 829.80M | 417.27M | 258.66M | 538.59M | 528.10M | 491.50M | 556.73M | 538.31M | 531.80M |
| Net Income | 6.75B | 6.78B | 5.76B | 6.52B | 4.33B | 4.19B | 3.75B | 4.33B | 4.23B | 3.46B | 3.02B | 2.03B | 1.81B | 1.51B | 1.80B | 1.79B | 1.31B | 898.22M | 1.40B | 1.25B |
| Net Income Ratio | 16.05% | 17.37% | 15.18% | 18.26% | 14.44% | 14.24% | 15.26% | 18.65% | 17.05% | 14.84% | 14.75% | 12.06% | 13.97% | 15.06% | 19.88% | 23.10% | 19.84% | 16.62% | 24.62% | 18.19% |
| EPS | 207.95 | 208.91 | 177.37 | 200.79 | 133.42 | 129.12 | 115.40 | 133.31 | 130.16 | 106.63 | 93.04 | 62.61 | 55.85 | 46.48 | 55.38 | 55.10 | 40.48 | 27.67 | 42.98 | 38.39 |
| EPS Diluted | 207.95 | 208.91 | 177.37 | 200.79 | 133.42 | 129.12 | 115.40 | 133.31 | 130.16 | 106.63 | 93.04 | 62.61 | 55.85 | 46.48 | 55.38 | 55.10 | 40.48 | 27.67 | 42.98 | 38.39 |
| Weighted Avg Shares Out | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M |
| Weighted Avg Shares Out (Dil) | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M | 32.46M |
Source: https://incomestatements.info
Category: Stock Reports